Sanofi (SNY) reported Q2 earnings Thursday of 3.24 euros ($3.71) per share, up from 0.89 euro a year earlier.
Net sales for the quarter ended June 30 were 9.99 billion euros, up from 9.43 billion euros a year earlier.
For 2025, the company said it now expects sales to grow by a high single-digit percentage at CER versus its prior outlook of mid-to-high single-digit.
Sanofi shares were down 4.6% in recent premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。